The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

Share Price Information for Biome Tech (BIOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 85.00
Bid: 70.00
Ask: 100.00
Change: 0.00 (0.00%)
Spread: 30.00 (42.857%)
Open: 85.00
High: 85.00
Low: 85.00
Prev. Close: 85.00
BIOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share option awards in lieu of historic bonuses

30 Jan 2020 16:10

RNS Number : 4849B
Biome Technologies PLC
30 January 2020
 

 

 

30 January 2020

Biome Technologies plc

 ("Biome", "the Company" or "the Group")

 

Share option awards in lieu of historic bonuses

 

Notification of transactions by directors/persons discharging managerial responsibilities

 

 

As noted in the Company's report and accounts for the year ended 31 December 2018, the Board's remuneration committee provisionally granted bonuses to Biome's Executive Directors, Paul Mines and Declan Brown in relation to the 2018 financial year. These bonuses have been accrued but not paid.

The Company announces that the following share options have been granted in respect of all unpaid bonus amounts in lieu of cash payments.

 

 

Name of Individual

 

Number of shares under option

 

Exercise price per share

Paul Mines (Director)

26,666

5 pence

Declan Brown (Director)

18,733

5 pence

Total

45,399

 

 

 

These share options can be exercised at any time until 30 April 2022. No shares that are issued from options exercised can be sold, other than to settle any tax liability directly associated with the exercise of these share options, before 30 April 2020. The Board has resolved that Mr Brown's 18,733 options will not lapse when he leaves the Group, which, as previously announced is anticipated to occur at the end of April 2020.

 

 

The FCA notification, made in accordance with the requirements of the EU Market Abuse Regulation is appended below and gives further details on the option grants for directors and persons discharging managerial responsibilities (PDMRs).

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Paul Mines

2

Reason for the notification

a)

Position/status

Director - Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Biome Technologies plc

b)

LEI

213800B9QI14B12TAO51

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 5p in Biome Technologies plc. Identification code (ISIN) for Biome Technologies plc ordinary shares: GB00B9Z1M820

b)

Nature of the transaction

Grant of option over ordinary shares of 5p in Biome Technologies plc

c)

Price(s) and volume(s)

Price(s)

Volume(s)

5 pence

Option to acquire 26,666 shares

 

d)

Aggregated information

- Aggregated volume

- Price

 

Single transaction as in 4 c) above. An option to acquire 26,666 shares in Biome Technologies plc at 5 pence per share.

e)

Date of the transaction

30 January 2020

f)

Place of the transaction

Outside of trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Declan Brown

2

Reason for the notification

a)

Position/status

Director - Group Finance Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Biome Technologies plc

b)

LEI

213800B9QI14B12TAO51

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 5p in Biome Technologies plc. Identification code (ISIN) for Biome Technologies plc ordinary shares: GB00B9Z1M820

b)

Nature of the transaction

Grant of option over ordinary shares of 5p in Biome Technologies plc

c)

Price(s) and volume(s)

Price(s)

Volume(s)

5 pence

Option to acquire 18,733 shares

 

d)

Aggregated information

- Aggregated volume

- Price

 

Single transaction as in 4 c) above. An option to acquire 18,733 shares in Biome Technologies plc at 5 pence per share.

e)

Date of the transaction

30 January 2020

f)

Place of the transaction

Outside of trading venue

 

 

 

-Ends-

 

 

 

 

 

For further information please contact: Biome Technologies plc

 

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Broker)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBLGDBRGXDGGG
Date   Source Headline
17th Oct 20065:54 pmRNSNotifiable Interest
17th Oct 200610:44 amRNSNotifiable Interest
16th Oct 20063:17 pmRNSNotifiable Interest
12th Oct 200612:35 pmRNSDoc re. Posting of Prospectus
11th Oct 20061:09 pmRNSNotifiable Interest
9th Oct 200611:13 amRNSProposed Placing & Open Offer
5th Oct 200610:25 amRNSFinancing Update
3rd Oct 200612:56 pmRNSStatement re. Press Comment
2nd Oct 20064:41 pmRNSSecond Price Monitoring Extn
2nd Oct 20064:35 pmRNSPrice Monitoring Extension
8th Sep 20067:01 amRNSTrading Statement
17th Aug 20067:44 amRNSTrading Statement
16th Aug 20065:52 pmRNSAdditional Listing - AMEND
14th Aug 200611:55 amRNSAdditional Listing
10th Aug 200612:25 pmRNSRe Contract
14th Jul 20067:56 amRNSInterim Results - Replacement
14th Jul 20067:00 amRNSInterim Results
2nd Jun 200611:26 amRNSNew Ord Share Placing-Amendmt
2nd Jun 20068:45 amRNSNew Ordinary Share Placing
25th May 20067:02 amRNSWrap 100 FDA approval
16th May 200610:43 amRNSAdditional Listing
15th May 20067:01 amRNSAppointment of Adviser
3rd May 20061:05 pmRNSNotifiable Interest
2nd May 20064:58 pmRNSResult of AGM
2nd May 20062:00 pmRNSAGM Statement
10th Apr 20063:12 pmRNSAnnual Report and Accounts
7th Apr 20062:46 pmRNSAdditional Listing
13th Mar 20067:02 amRNSDirectorate Change
28th Feb 20067:02 amRNSPreliminary Results
24th Feb 20067:02 amRNSCooperation with Wal-Mart
14th Feb 20069:07 amRNSAdditional Listing
14th Feb 20067:00 amRNSUS FDA approval for Starpol
9th Feb 200610:42 amRNSIsraCaps new licence terms
9th Feb 20067:02 amRNSRe: BioProgress plc
16th Dec 20057:01 amRNSFunding for R&D facility
16th Dec 20057:01 amRNSPre Close Update
14th Dec 20057:01 amRNSLandmark deal with Perseco
8th Dec 200510:25 amRNSShare Listing Application
30th Nov 20055:40 pmRNSDirectorate Change
28th Nov 20059:24 amRNSBoard Changes
8th Nov 20057:01 amRNSPatent sale process update
3rd Nov 20054:47 pmRNSExercise of Options
1st Nov 20057:02 amRNSChange of Adviser
12th Oct 20057:00 amRNSApproval of Starpol
3rd Oct 20057:00 amRNSPatent Disposal & Update
22nd Sep 20057:02 amRNSRe Agreement
12th Sep 20057:03 amRNSDevelopment of capsule
5th Sep 20057:03 amRNSRe: Completion
30th Aug 20053:30 pmRNSDoc re. Result of EGM
30th Aug 200511:08 amRNSEGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.